Senzime AB (publ)
SSE:SEZI.ST
7.25 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Senzime AB (publ) |
Symbool | SEZI.ST |
Munteenheid | SEK |
Prijs | 7.25 |
Beurswaarde | 673,380,247 |
Dividendpercentage | 0% |
52-weken bereik | 2.605 - 8.46 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Philip Siberg |
Website | https://senzime.com |
An error occurred while fetching data.
Over Senzime AB (publ)
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)